Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

OptimizeRx (OPRX) Total Debt: 2010-2024

Historic Total Debt for OptimizeRx (OPRX) over the last 5 years, with FY2024 value amounting to $32.8 million.

  • OptimizeRx's Total Debt fell 2034.41% to $28.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $28.1 million, marking a year-over-year decrease of 2034.41%. This contributed to the annual value of $32.8 million for FY2024, which is 942.56% down from last year.
  • As of FY2024, OptimizeRx's Total Debt stood at $32.8 million, which was down 942.56% from $36.2 million recorded in FY2023.
  • In the past 5 years, OptimizeRx's Total Debt registered a high of $36.2 million during FY2023, and its lowest value of $285795.0 during FY2020.
  • Its 3-year average for Total Debt is $23.1 million, with a median of $32.8 million in 2024.
  • In the last 5 years, OptimizeRx's Total Debt plummeted by 5072.62% in 2020 and then tumbled by 942.56% in 2024.
  • OptimizeRx's Total Debt (Annual) stood at $285795.0 in 2020, then surged by 12577.27% to $36.2 million in 2023, then decreased by 9.43% to $32.8 million in 2024.
  • Its Total Debt stands at $32.8 million for FY2024, versus $36.2 million for FY2023 and $285795.0 for FY2020.